CODX vs TROW
Co-Diagnostics, Inc. Common Stock (CODX) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
CODX currently screens at market cap $31.4M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the CODX and TROW stock pages for the full models.
Not investment advice.